| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-0327(00)00162-2 |
| P698 | PubMed publication ID | 11426515 |
| P2093 | author name string | Zhang F | |
| Burns P | |||
| Tohen M | |||
| Taylor CC | |||
| Tollefson G | |||
| Zarate C | |||
| Sanger T | |||
| P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
| Meta-analysis in clinical research | Q29620885 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. | Q34246646 | ||
| Can meta-analyses be trusted? | Q34545407 | ||
| Valproate in the treatment of acute mania. A placebo-controlled study | Q34613045 | ||
| Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. | Q34744028 | ||
| Adjunctive clonazepam for maintenance treatment of bipolar affective disorder | Q37808406 | ||
| Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic | Q40619229 | ||
| Role of newer medications for bipolar disorder | Q41033546 | ||
| Chronic neuroleptic exposure in bipolar outpatients. | Q41498608 | ||
| Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium | Q41640883 | ||
| Olanzapine compared to lithium in mania: a double-blind randomized controlled trial | Q46146139 | ||
| Beyond lithium in the treatment of bipolar illness | Q48435421 | ||
| Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. | Q51990338 | ||
| Response to clozapine in acute mania is more rapid than that of chlorpromazine. | Q53972337 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q61480116 | ||
| The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder | Q63446703 | ||
| Outcome in manic disorders. A naturalistic follow-up study | Q67301345 | ||
| Verapamil versus lithium in acute mania | Q67719817 | ||
| Prospective studies on a lithium cohort. 1. General features | Q68034843 | ||
| Tardive dyskinesia in bipolar affective disorder: a catchment area study | Q68307654 | ||
| Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis | Q68610336 | ||
| Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients | Q68915536 | ||
| Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia | Q69377160 | ||
| A comparison of in-patient and out-patient prescribing | Q69377272 | ||
| Persistent tardive dyskinesia in bipolar patients | Q69878537 | ||
| Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia | Q69926625 | ||
| A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania | Q70539313 | ||
| Prediction of treatment response in mania | Q70818497 | ||
| Clozapine for treatment-refractory mania | Q71085936 | ||
| A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients | Q71496543 | ||
| Neuroleptics in acute mania: a pharmacoepidemiologic study | Q71901372 | ||
| Course of the Manic-Depressive Cycle and Changes Caused by Treatments | Q72441891 | ||
| Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting | Q72536917 | ||
| Valproate as a loading treatment in acute mania | Q72586334 | ||
| Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases | Q72891466 | ||
| P433 | issue | 1 | |
| P921 | main subject | meta-analysis | Q815382 |
| bipolar disorder | Q131755 | ||
| P304 | page(s) | 85-93 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Journal of Affective Disorders | Q15716493 |
| P1476 | title | A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. | |
| P478 | volume | 65 |
| Q46170156 | A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder |
| Q33268080 | Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. |
| Q33661489 | Can Antipsychotic Agents be Considered as Real Antimanic Treatments? |
| Q33583969 | Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity |
| Q37643038 | Clinical Practice Guidelines for Management of Bipolar Disorder |
| Q36905876 | Depot antipsychotic medications in bipolar disorder: a review of the literature |
| Q24601815 | Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q35212737 | Issues in the treatment of bipolar disorder |
| Q33529314 | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis |
| Q37960632 | Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review |
| Q44272762 | Pharmacotherapy patterns in the treatment of bipolar disorder |
| Q37481603 | Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders |
| Q34606256 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania |
| Q51933587 | Time to remission and relapse after the first hospital admission in severe bipolar disorder. |
| Q37973144 | Treatment of mixed bipolar states |
| Q37665567 | Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis |
| Q36106843 | Use of olanzapine in the treatment of bipolar I disorder |
| Q83866936 | Ziprasidone in bipolar disorder |
Search more.